CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | -50.0% | 140 | -39.1% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 230 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 230 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | +100.0% | 230 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 230 | -51.1% | 0.00% | – |
| Q3 2016 | $2,000 | -33.3% | 470 | -33.8% | 0.00% | – |
| Q2 2016 | $3,000 | 0.0% | 710 | 0.0% | 0.00% | – |
| Q1 2016 | $3,000 | -50.0% | 710 | -40.8% | 0.00% | – |
| Q4 2015 | $6,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
| BlackRock Inc. | 110,990 | $209,771 | 0.00% |
| Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |